Blunted fetal growth by tenofovir in late pregnancy

AIDS

Volumn 26, Issue 16, 2012, Pages 2119-2120

  Kinai, Ei ^a   Hosokawa, Shinichi ^a   Gomibuchi, Hideto ^a   Gatanaga, Hiroyuki ^a   Kikuchi, Yoshimi ^a   Oka, Shinichi ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; LOPINAVIR PLUS RITONAVIR; RALTEGRAVIR; TENOFOVIR DISOPROXIL;

ADULT; BLUNTED FETAL GROWTH; CASE REPORT; DRUG BLOOD LEVEL; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FETUS GROWTH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PRIORITY JOURNAL; SIDE EFFECT; THIRD TRIMESTER PREGNANCY;

ADENINE; ADULT; ANTI-HIV AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; BONE DENSITY; FEMALE; FETAL GROWTH RETARDATION; HEPATITIS B; HIV SEROPOSITIVITY; HUMANS; INFANT, NEWBORN; ORGANOPHOSPHONATES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84867731203     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328358ccaa     Document Type: Letter

References (5)

1. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. 2011. http://aidsinfo.nih. gov/ContentFiles/PerinatalGL.pdf.
2. McComsey GA, Kitch D, Daar ES, Tierney C, Jahed NC, Tebas P, et al. Bone mineral density and fracrtures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: AIDS clinical trials group A5224s, a substudy of ACTG A5202. J Infect Dis 2011; 203: 1791-1801.
3. Van Rompay KKA, Brignolo LL, Meyer DJ, Jerome C, Tarara R, Spinner A, et al. Biological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy) propyl] adenine (tenofovir) to newborn and infant rhesus macaques. Antimicrob Agents Chemother 2004; 48:1469-1487.
4. Siberry GK, Williams PL, Mendez H, Seage GR, Jacobson DL, Hazra R, et al., for the Pediatric HIV/AIDS Cohort Study (PHACS). Safety of tenofovir use during pregnancy; early growth outcomes in HIV-exposed uninfected infants. AIDS 2012; 26:1151-1159.
5. Flynn PA, Mirochnick M, Shapiro DE, Bardequez A, Rodman J, Robbins B, et al., PACTG 394 Study Team. Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infants. Antimicrob Agents Chemother 2011; 55:5914-5922.